Results 61 to 70 of about 1,551 (70)

A Broad Overview of Signaling in Ph-Negative Classic Myeloproliferative Neoplasms

Cancers, 2021
JOSÉ Luis Vizmanos, Ana Guijarro-Hernández   +1 more
exaly  

Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications

International Journal of Molecular Sciences, 2022
Antonella Poloni, Erika Morsia, Elena Torre   +2 more
exaly  

Advances in Understanding and Management of Myeloproliferative Neoplasms

Ca-A Cancer Journal for Clinicians, 2009
Alessandro Maria Vannucchi, Paola Guglielmelli, Ayalew Tefferi   +2 more
exaly  

Thrombosis in Myeloproliferative Neoplasms

Seminars in Thrombosis and Hemostasis, 2014
Marina Marchetti, Anna Falanga
exaly  

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis

Frontiers in Oncology, 2020
Bing Han, Ziqi Wan
exaly  

Inherited predisposition to myeloproliferative neoplasms

Therapeutic Advances in Hematology, 2013
Nicholas Cross, Amy V Jones
exaly  

Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms

Cancer Cell, 2018
Keith Cordner, Corinne E Hill, Raajit Rampal   +2 more
exaly  

Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms

Leukemia and Lymphoma, 2012
Ruben Mesa, Gunnar Birgegård, Björn Andréasson   +2 more
exaly  

JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment

Therapeutic Advances in Hematology, 2011
Alessandro Maria Vannucchi, Paola Guglielmelli, Lisa Pieri   +2 more
exaly  

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms

Scientific World Journal, The, 2011
Marina Marchetti, Anna Falanga, Fabrizio Vianello   +2 more
exaly